This handout is for inferior wall stemi (rca / lcx culprit). Your care team identified this based on: st elevation ii/iii/avf + reciprocal st↓ i/avl (inferior stemi).
Other reasons your team may use this plan: ischemic chest pain + inferior stemi ecg → emergent cath within 90 min; inferior stemi on standard ecg → mandatory v4r lead to screen for rv extension.
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| aspirin | 162-325 mg chewed | PO | load + 81 mg daily | ACC/AHA 2025 ACS Class I; same as parent |
| ticagrelor | 180 mg load → 90 mg BID | PO | BID × 12 mo default DAPT | PLATO PMID 19717846; same as parent |
| atropine | 0.5 mg IV q3-5 min, max 3 mg | IV | PRN | Vagal-mediated bradycardia (Bezold-Jarisch reflex) common in inferior MI; first-line per Kusumoto 2018 PMID 30412709 |
| metoprolol | 12.5-25 mg PO BID — DEFER until rhythm stable | PO | deferred | BB normally Class I post-MI, but AVOID/defer in acute inferior MI if HR <60, 2°-3° AV block, or hypotension; reintroduce after 48h once rhythm stable — encoded as contraindication_substitute (avoid in this phenotype, restart in chronic management arm) |
Plan: Inferior STEMI complication phenotype — adds to parent cardio.stemi.core.v1 reperfusion regimen
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Cardiology follow-up; echo at 40 d for heart pumping strength (LVEF) reassessment; cardiac rehab; lower ICD-eligibility rate than anterior (smaller infarct typically)
Guideline: 2025 ACC/AHA ACS Guideline + ESC 2023 ACS + 2018 ACC/AHA/HRS Bradycardia Guideline